A randomised, double-blind, placebo-controlled, factorial-design trial to assess the effect of aspirin and fish oil (omega-3 fatty acids) in the prevention of early thrombosis in arterio-venous fistulae in patients with Stage IV or V chronic kidney disease requiring haemodialysis.
Phase of Trial: Phase II/III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Aspirin (Primary) ; Omega 3 fatty acids (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Acronyms FAVOURED
- 02 Apr 2015 Status changed from recruiting to completed as per Australian New Zealand Clinical Trials Registry record .
- 31 May 2012 Additional lead trial centre added as reported by United Kingdom Clinical Research Network.
- 22 Mar 2012 Planned end date (Mar 2014) added as reported by United Kingdom Clinical Research Network.